Prevalence of hepatitis C among diabetes mellitus patients in Zahedan

Maliheh  Metanat; Batool  Sharifi-Mood; Esmail Sanei-Moghadam; Roya  Alavi-Naini; M Naderi; Soheila Khosravi; AR Shahraki

Zahedan Journal of Research in Medical Sciences

The Official Journal of Zahedan University of Medical Sciences

Current Issue All Issues In Press Articles Accepted Manuscripts Search

Journal Information Boards and Committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Contact Us Support Reviewer and AE Registration Form

APC

Authors Guide Submit Manuscript

Prevalence of hepatitis C among diabetes mellitus patients in Zahedan

Author(s):

Maliheh Metanat^1,*,

Batool Sharifi-Mood¹,

Esmail Sanei-Moghadam¹,

Roya Alavi-Naini¹,

M Naderi¹,

Soheila Khosravi²,

AR Shahraki²

1Infectious Disease Dept, Faculty of Medicine, Zahedan University of Medicine Sciences and Health Services, Zahedan, Iran.

2South Eastern Center of Blood Transfusion Organization, Zahedan, Iran.

Zahedan Journal of Research in Medical Sciences:Vol. 8, issue 3; e94894

Published online:Sep 03, 2006

Article type:Research Article

Received:Jul 22, 2006

Accepted:Aug 12, 2006

How to Cite:Maliheh MetanatBatool Sharifi-MoodEsmail Sanei-MoghadamRoya Alavi-NainiM NaderiSoheila KhosraviAR Shahrakiet al.Prevalence of hepatitis C among diabetes mellitus patients in Zahedan.Zahedan J Res Med Sci.8(3):e94894.

Abstract

Background: Several clinical studies have recently claimed that HCV infection could trigger the
onset of diabetes mellitus (DM). In order to determine the prevalence of hepatitis C virus (HCV)
among patients with type 1, 2 diabetes mellitus (DM) and investigate the influence of several
epidemiological factors on HCV infection, we conducted this study.
Materials and Methods: In this case-control study we evaluated 505 diabetic patients (135 male,
370 female with the mean age of 54.5 years) who had referred to Diabetic clinic in Boo-Ali hospital
(a teaching hospital in south east of Iran) in 2004. Serologic testing for anti- HCV was done using a
third–generation commercial Enzyme–Linked Immunosorbent Assay (ELISA) and Real–time–PCR
(HCV RNA) in order to confirm the anti-HCV positive samples. Diabetic patients were divided in
two groups according to their HCV antibody status and were analyzed for the following variables:
age, sex, type of diabetes, duration of disease, mode of therapy, late diabetic complication, previous
blood transfusions, intravenous drug addiction, hospital admissions and major surgical procedures.
Then results were compared with the findings from blood donors.
Results: HCV infection was detected in one patient who had history of hospitalization and blood
transfusion. However, a higher prevalence of HCV infection was not observed in diabetic patients
in comparison with blood donors (P=0.46).There was no correlation between HCV and diabetic
type, duration, age, sex (P>0.05).
Conclusions: Upon the results of our study, we conclude that HCV infection is not a trigger
factor for DM; therefore it should not be listed among the various extrahepatic manifestations of
this viral infection. Although, further studies, possibly multicentre, are needed to estimate
prevalence of HCV in diabetic patients.

Keywords

Fulltext

The full text of this article is available on the PDF file.

References

1.
The References of this article are available on the PDF file.

comments